**Title:** Former Lazard Banker Charged in Insider Trading Scheme
**Meta Description:** A former Lazard banker faces criminal charges for insider trading, allegedly leaking healthcare deal information that led to $41 million in illicit profits.
**URL Slug:** lazard-banker-insider-trading-charges
**Headline:** Former Lazard Dealmaker Faces Criminal Charges for Insider Trading in Healthcare Deals
A former dealmaker at Lazard Ltd., a leading investment bank on Wall Street, has been charged by U.S. authorities for allegedly providing insider information about healthcare transactions to a network of traders, resulting in $41 million in illegal profits. Justin Kim, who is now facing both criminal and regulatory charges, reportedly leaked details about ten potential takeovers over several years, up until 2023. According to a complaint from the U.S. Securities and Exchange Commission (SEC), Kim received a Rolex watch and career advice in exchange for the confidential information, prompting the SEC to seek a ban on his future participation in the industry.
In a significant development last month, the Department of Justice announced fraud and insider trading charges against Kim, which could lead to a prison sentence of up to 25 years. The allegations involve his friend, Muhammad Saad Shoukat, and two of his brothers, who allegedly capitalized on the insider information to make well-timed investments ahead of major acquisitions. Notable deals mentioned include Gilead Sciences Inc.’s $21 billion acquisition of Immunomedics Inc. in 2020, CVS Health Corp.’s $10.6 billion buyout of Oak Street Health Inc., and AbbVie Inc.’s $10.1 billion purchase of ImmunoGen Inc. in 2023—three of the largest transactions in the healthcare sector that Lazard advised on in the past decade.
While Lazard itself is not accused of any wrongdoing, the unfolding scheme comes at a time when CEO Peter Orszag is focused on strengthening the firm’s healthcare division amid a rise in global mergers and acquisitions. Reports indicate that the illegal tips allegedly preceded deals worth over $60 billion, according to calculations by Bloomberg.
In a text message to Shoukat in April 2023, shortly after learning about ImmunoGen’s negotiations with AbbVie, Kim allegedly wrote, “Get ready bro, S—— is about to pop off.” Stefanie Roddy, the special agent in charge of the FBI’s Newark office, stated, “Shoukat and his co-conspirators benefited greatly from their years-long scheme and cheated the system to reap their rewards.”
Attorneys representing Kim have not responded to requests for comment, nor has former New Jersey Governor Chris Christie, who is representing the Shoukat brothers. A spokesperson for Lazard emphasized the firm’s commitment to ethical conduct, stating, “We have zero tolerance for conduct that does not adhere to our standards. The allegations against this junior banker, who has not been employed by the firm since 2023, are brazenly criminal and a clear violation of our policies, and we are fully cooperating with authorities.”
Charges against the Shoukat brothers and two other defendants were filed in July, but it wasn’t until late November that Kim was charged in New Jersey. He was arrested shortly thereafter in San Francisco, later posting $100,000 bail and has yet to enter a plea. Although the complaints do not specify where Kim was employed at the time, industry records confirm his position at Lazard, which served as an advisor on the deals referenced in the allegations.
**FAQ:**
**What are the charges against Justin Kim?**
Justin Kim faces criminal and regulatory charges for insider trading, accused of leaking confidential information about healthcare deals that resulted in $41 million in illicit profits.